NightHawk Biosciences (NHWK) Short Interest Ratio & Short Volume → Elon Musk’s Controversial New Project: “Apollo” (From InvestorPlace) (Ad) Free NHWK Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock AnalysisEarningsHeadlinesInsider TradesSocial MediaStock AnalysisEarningsHeadlinesInsider TradesSocial Media NightHawk Biosciences Short Interest DataCurrent Short Volume872,800 sharesPrevious Short Volume835,400 sharesChange Vs. Previous Month+4.48%Dollar Volume Sold Short$2.44 millionShort Interest Ratio / Days to Cover5.5Last Record DateApril 15, 2022Outstanding Shares26,080,000 sharesFloat Size24,320,000 sharesShort Percent of Float3.59%Today's Trading Volume173,100 sharesAverage Trading Volume97,242 sharesToday's Volume Vs. Average178% Short Selling NightHawk Biosciences ? Sign up to receive the latest short interest report for NightHawk Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatNHWK Short Interest Over TimeNHWK Days to Cover Over TimeNHWK Percentage of Float Shorted Over Time Ad InvestorPlaceElon Musk’s Controversial New Project: “Apollo”Have you seen this footage outside the headquarters of Elon Musk's "Project Apollo?" Big Tech and the mainstream media have called this project "controversial"...Click here to see the details because there's a lot of money at stake. NightHawk Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2022872,800 shares $2.44 million +4.5%3.6%5.5 $2.80 3/31/2022835,400 shares $2.56 million +14.7%3.4%5.1 $3.06 3/15/2022728,600 shares $1.53 million -18.3%3.0%3.5 $2.10 2/28/2022891,400 shares $2.32 million -15.1%3.7%4.4 $2.60 2/15/20221,050,000 shares $2.98 million -5.4%4.4%4.7 $2.84 1/31/20221,110,000 shares $3.24 million +4.7%4.6%4.3 $2.92 Get the Latest News and Ratings for NHWK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NightHawk Biosciences and its competitors with MarketBeat's FREE daily newsletter. 1/15/20221,060,000 shares $3.21 million -12.4%N/A3.8 $3.03 12/31/20211,210,000 shares $3.68 million +3.4%5.0%4.6 $3.04 12/15/20211,170,000 shares $4.75 million -26.9%4.9%4.7 $4.06 11/30/20211,600,000 shares $7.18 million +4.6%6.6%6.7 $4.49 11/15/20211,530,000 shares $7.51 million -11.1%6.3%5.7 $4.91 10/29/20211,720,000 shares $9.18 million -17.3%7.1%6.8 $5.34 10/15/20212,080,000 shares $11.90 million -2.8%8.6%8.4 $5.72 9/30/20212,140,000 shares $12.73 million -10.5%8.8%8.7 $5.95 9/15/20212,390,000 shares $14.63 million +0.8%9.8%8.9 $6.12 8/31/20212,370,000 shares $17.14 million -16.8%9.8%2.6 $7.23 8/13/20212,850,000 shares $18.21 million No Change11.7%3.2 $6.39 7/30/20212,850,000 shares $18.04 million -7.2%11.7%3.1 $6.33 7/15/20213,070,000 shares $19.19 million +11.6%12.6%3.2 $6.25 6/30/20212,750,000 shares $18.51 million +8.3%11.3%2.8 $6.73 6/15/20212,540,000 shares $17.83 million +8.6%10.5%2.6 $7.02 5/28/20212,340,000 shares $15.47 million -5.7%9.7%2.6 $6.61 5/14/20212,480,000 shares $14.33 million -5.0%10.3%4.1 $5.78 4/30/20212,610,000 shares $18.27 million -9.4%10.8%1.3 $7.00 4/15/20212,880,000 shares $19.53 million +21.5%11.9%1.3 $6.78 3/31/20212,370,000 shares $16.40 million -7.1%9.6%1 $6.92 3/15/20212,550,000 shares $23.10 million +26.2%11.5%1 $9.06 2/26/20212,020,000 shares $15.98 million -0.5%9.1%0.7 $7.91 2/12/20212,030,000 shares $24.04 million +6.3%9.2%0.8 $11.84 1/29/20211,910,000 shares $13.62 million -9.1%8.6%0.8 $7.13 1/15/20212,100,000 shares $13.04 million -9.9%9.5%1.8 $6.21 12/31/20202,330,000 shares $12.75 million +6.9%10.5%2.4 $5.47 12/15/20202,180,000 shares $12.64 million -72.5%9.9%2.4 $5.80 11/30/20207,940,000 shares $9.05 million -12.7%N/A1.2 $1.14 11/15/20209,090,000 shares $9.64 million -8.8%N/A1.1 $1.06 10/30/20209,970,000 shares $11.57 million +8.7%N/A0.9 $1.16 10/15/20209,170,000 shares $12.56 million -18.8%N/A0.6 $1.37 9/30/202011,290,000 shares $14.00 million +58.4%N/A0.4 $1.24 9/15/20207,130,000 shares $7.99 million -8.9%N/A0.2 $1.12 8/31/20207,830,000 shares $9.87 million +52.9%N/A0.3 $1.26Elon Musk’s Controversial New Project: “Apollo” (Ad)Have you seen this footage outside the headquarters of Elon Musk's "Project Apollo?" Big Tech and the mainstream media have called this project "controversial"...Click here to see the details because there's a lot of money at stake. NHWK Short Interest - Frequently Asked Questions What is NightHawk Biosciences' current short interest? Short interest is the volume of NightHawk Biosciences shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 872,800 shares of NHWK short. 3.59% of NightHawk Biosciences' shares are currently sold short. Learn More on NightHawk Biosciences' current short interest. What is a good short interest ratio for NightHawk Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NHWK shares currently have a short interest ratio of 6.0. Learn More on NightHawk Biosciences's short interest ratio. What is a good short interest percentage for NightHawk Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.59% of NightHawk Biosciences' floating shares are currently sold short. Is NightHawk Biosciences' short interest increasing or decreasing? NightHawk Biosciences saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 872,800 shares, an increase of 4.5% from the previous total of 835,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is NightHawk Biosciences' float size? NightHawk Biosciences currently has issued a total of 26,080,000 shares. Some of NightHawk Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. NightHawk Biosciences currently has a public float of 24,320,000 shares. How does NightHawk Biosciences' short interest compare to its competitors? 3.59% of NightHawk Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to NightHawk Biosciences: Eterna Therapeutics Inc. (1.42%), Galera Therapeutics, Inc. (4.07%), Guardion Health Sciences, Inc. (13.71%), Moleculin Biotech, Inc. (2.09%), Monopar Therapeutics Inc. (2.29%), Elevai Labs, Inc. (0.19%), Alterity Therapeutics Limited (0.28%), Akari Therapeutics, Plc (0.16%), Aeterna Zentaris Inc. (0.45%), Purple Biotech Ltd. (0.88%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Palo Alto Networks, Inc. ($4.77 billion), Charter Communications, Inc. ($4.21 billion), HP Inc. ($2.60 billion), Lucid Group, Inc. ($2.33 billion), GameStop Corp. ($2.13 billion), Rivian Automotive, Inc. ($2.10 billion), Wayfair Inc. ($1.96 billion), Carnival Co. & plc ($1.81 billion), Teladoc Health, Inc. ($1.66 billion), and Plug Power Inc. ($1.63 billion). View all of the most shorted stocks. What does it mean to sell short NightHawk Biosciences stock? Short selling NHWK is an investing strategy that aims to generate trading profit from NightHawk Biosciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against NightHawk Biosciences? A short squeeze for NightHawk Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NHWK, which in turn drives the price of the stock up even further. How often is NightHawk Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NHWK, twice per month. The most recent reporting period available is April, 15 2022. More Short Interest Resources from MarketBeat Related Companies: Eterna Therapeutics Short Interest Galera Therapeutics Short Interest Guardion Health Sciences Short Interest Moleculin Biotech Short Interest Monopar Therapeutics Short Interest Elevai Labs Short Interest Alterity Therapeutics Short Interest Akari Therapeutics Short Interest Aeterna Zentaris Short Interest Purple Biotech Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:NHWK) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencySHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”AltimetryThe Greatest Bull Market in Crypto History…Weiss RatingsFed launches fourth dollar overhaulStansberry Research